Role of Myocardial Perfusion Imaging in Patients With End-Stage Renal Disease Undergoing Coronary Angiography

American Journal of Cardiology

Volumn 102, Issue 11, 2008, Pages 1451-1456

  Venkataraman, Rajesh ^a   Hage, Fadi G ^a   Dorfman, Todd ^a   Heo, Jaekyeong ^a   Aqel, Raed A ^a   de Mattos, Angelo M ^b   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; MYOCARDIAL REPERFUSION; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 56349119571     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.029     Document Type: Article

References (29)

1. Foley R.N., Parfrey P.S., and Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 suppl (1998) S16-S23
2. US Renal Data System. Appendix H: mortality and causes of death. USRDS 2000 Annual Data Report (2000), National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD 659
3. Foley R.N., Murray A.M., Li S., Herzog C.A., McBean A.M., Eggers P.W., and Collins A.J. Chronic kidney disease and the risk of cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998-1999. J Am Soc Nephrol 16 (2005) 489-495
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
5. Muntner P., Hamm L.L., Kusek J.W., Chen J., Whelton P.K., and He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140 (2004) 1409-1417
6. Kasiske B.L. Ischemic heart disease after renal transplantation. Kidney Int 61 (2002) 356-369
7. Logar C.M., Herzog C.A., and Beddhu S. Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci 325 (2003) 214-227
8. Kasiske B.L., Cangro C.B., Hariharan S., Hricik D.E., Kerman R.H., Roth D., Rush D.N., Vazquez M.A., Weir M.R., and American Society of Transplantation. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1 suppl 2 (2001) 3-95
9. EBPG (European Expert Group on Renal Transplantation), European Renal Association (ERA-EDTA), and European Society for Organ Transplantation (ESOT). European Best Practice Guidelines for Renal Transplantation (part 1). Nephrol Dial Transplant 15 suppl 7 (2000) 1-85
10. Hage F.G., Smallheiser S., Zoghbi G.J., Perry G.J., Deierhoi M., Warnock D., Iskandrian A.E., de Mattos A.M., and Aqel R.A. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol 100 (2007) 1020-1025
11. Siedlecki A., Foushee M., Curtis J.J., Gaston R.S., Perry G.J., Iskandrian A.E., and de Mattos A.M. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation 84 (2007) 1610-1617
12. Hage F.G., Dubovsky E.V., Heo J., and Iskandrian A.E. Outcome of patients with adenosine induced ST segment depression but with normal perfusion on tomographic images. Am J Cardiol 98 (2006) 1009-1011
13. Ficaro E.P., Lee B.C., Kritzman J.N., and Corbett J.R. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol 14 (2007) 455-465
14. Borges-Neto S., Shaw L.K., Tuttle R.H., Alexander J.H., Smith W.T., Chambless M., Coleman E.R., Harrington R.A., and Califf R.M. Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. Am J Cardiol 95 (2005) 182-188
15. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., Freidman J., and Diamond G.A. Incremental prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of cardiac death. Differential stratification for risk of cardiac death and myocardial infarction. Circulation 93 (1996) 905-914
16. De Lima J.J.G., Sabbaga E., Vieira M.L.C., de Paula F.J., Ianhez L.E., Krieger E.M., and Ramires J.A.F. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42 (2003) 263-268
17. Marwick T., Steinmuller D., Underwood D.A., Hobbs R.F., Go R.T., Swift C., and Braun W.E. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal disease. Transplantation 49 (1990) 100-103
18. Trespalacios F.C., Taylor A.J., Agodoa L.Y., Bakris G.L., and Abbott K.C. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 41 (2003) 1267-1277
19. de Mattos A.M., Siedlecki A., Gaston R.S., Perry G.J., Julian B.A., Kew II C.E., Deierhoi M.H., Young C., Curtis J.J., and Iskandrian A.E. Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol 19 (2008) 1191-1196
20. Hase H., Joki N., Ishikawa H., Fukuda H., Imamura Y., Saijyo T., Tanaka Y., Takahashi Y., Inishi Y., Nakamura M., and Moroi M. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 19 (2004) 1161-1167
21. Rabbat C.G., Treleaven D.J., Russell J.D., Ludwin D., and Cook D.J. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 14 (2003) 431-439
22. Patel A.D., Bo-Auda W.S., Davis J.M., Zoghbi G.J., Deierhoi M.H., Heo J., and Iskandrian A.E. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 92 (2003) 146-151
23. Herzog C.A., Ma J.Z., and Collins A.J. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 109 (2004) 2866-2871
24. Sezgin A., Mercan S., Tasdelen A., Yaveri A., and Aslamaci S. Coronary bypass surgery in renal transplantation patients. Transplant Proc 30 (1998) 782-783
25. Iskandrian A.E., Heo J., Mehta D., Tauxe E.L., Yester M., Hall M.B., and MacGregor J.M. Gated SPECT perfusion imaging for the simultaneous assessment of myocardial perfusion and ventricular function in the BARI2D trial: an initial report from the Nuclear Core Laboratory. J Nucl Cardiol 13 (2006) 83-90
26. Zheng Z.J., Croft J.B., Giles W.H., and Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 (2001) 2158-2163
27. Herzog C.A., Strief J.W., Collins A.J., and Gilbertson D.T. Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?. Nephrol Dial Transplant 23 (2008) 2629-2633
28. Wase A., Basit A., Nazir R., Jamal A., Shah S., Khan T., Mohiuddin I., White C., Saklayen M., and McCullough P.A. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 11 (2004) 199-204
29. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for reassessment?. J Am Coll Cardiol 34 (1999) 618-620